i-SENS CareSens PRO, Руководство владельца

Страница: 28 / 29

52 www.i-sens.com www.i-sens.com 53
Difference Averages
NO Interferent
Interval 1 Interval 2
50–100 mg/dL 250–350 mg/dL
(2.8–5.5 mmol/L) (13.9–19.4 mmol/L)
20 Glutathione (Red) -1.0 mg/dL -0.8%
21 Hemoglobin -5.6 mg/dL -2.8%
22 Ibuprofen 1.7 mg/dL -0.9%
23 Icodextrin -2.8 mg/dL -0.4%
24 L-DOPA -2.4 mg/dL 0.0%
25 Methyl-DOPA -0.9 mg/dL -1.4%
26 Sodium salicylate 1.0 mg/dL 3.7%
27 Sucrose -0.3 mg/dL -1.1%
28 Tolazamide -0.3 mg/dL 0.5%
29 Tolbutamide 1.8 mg/dL 3.5%
30 Triglyceride -0.5 mg/dL 0.5%
31 Uric acid -0.5 mg/dL -0.6%
32 PAM -1.8 mg/dL 1.6%
User Performance Evaluation
A study evaluating glucose values from fingertip capillary blood
samples obtained by 100 lay persons showed the following results:
97.1% within ± 15 mg/dL (± 0.83 mmol/L) of the medical
laboratory values at glucose concentrations below 100 mg/dL
(5.55 mmol/L), and 99% within ±15% of the medical laboratory
values at glucose concentrations at or above 100 mg/dL
(5.55 mmol/L).
Compounds of xylose ≥ 9.69 mg/dL (0.54 mmol/L) at glucose
concentrations of 50-100 mg/dL (2.8–5.6 mmol/L) may cause
overestimation of blood glucose results.
Difference Averages
NO Interferent
1 Ascorbic acid -2.3 mg/dL 0.0%
2 Bilirubin 1.1 mg/dL 1.3%
3 EDTA 1.6 mg/dL 1.4%
4 Fructose 1.8 mg/dL -0.3%
5 Galactose -2.4 mg/dL -0.2%
6 Haparin -0.8 mg/dL -0.8%
7 Maltose -2.1 mg/dL -1.4%
8 Maltotriose -0.3 mg/dL -0.1%
9 Maltotetraose 0.4 mg/dL -0.7%
10 Mannose -1.1 mg/dL 3.5%
11 Xylose 33.8 mg/dL 8.9%
12 2-deoxyglucose 2.4 mg/dL 0.2%
13 Acetaminophen -0.9 mg/dL 2.7%
14 Cholesterol 0.7 mg/dL -0.3%
15 Creatinine 0.2 mg/dL -1.9%
16 D,L-arabinose 1.4 mg/dL 3.1%
17 Dopamine 0.4 mg/dL -0.3%
18 Gentisic acid 0.8 mg/dL 2.7%
19 Glucosamine -1.1 mg/dL -2.7%
Interval 1 Interval 2
50–100 mg/dL 250–350 mg/dL
(2.8–5.5 mmol/L) (13.9–19.4 mmol/L)
Interferences
The effect of various interfering substances was evaluated in
whole blood samples on glucose measurements.